Posts Tagged ‘Diagnostic’
LASCCO SA and Abionic SA announce a partnership to commercialize a sepsis diagnostic solution in China
LASCCO SA and Abionic SA, both based in Biopôle in Epalinges, announced that they have signed a licensing agreement with global life science company, Fapon for the use of the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This agreement initiates a strategic cooperation between LASCCO, Fapon and Abionic SA, LASCCO’s…
Read MoreHedera Dx Launches Blood Based Cancer Testing
Hedera Dx, a Vaud-based oncology company specializing in liquid biopsy testing, has unveiled a fully streamlined solution that allows hospitals to adopt liquid biopsy testing locally for their patients with minimal efforts. The solution is a combination of laboratory reagents and a software platform. Liquid biopsies provide rapid, precise, non-invasive ways of assessing…
Read MoreCSEM and MOMM Diagnostics partner to develop a rapid test for preeclampsia
Among the various pregnancy complications, one of the most serious and potentially life-threatening conditions is preeclampsia affecting 3 to 8% of pregnant women. It is characterized by high blood pressure and protein leakage in the urine, which can lead to kidney failure, liver failure, seizures, stroke and even death. Women with a family history of…
Read MoreGene Predictis is bought by NIMGenetics
The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed. NIMGenetics, a leading Spanish biotechnology company in the field of human genetic diagnostics, continues its expansion in Europe with the acquisition of the Swiss diagnostic company Gene Predictis, a leader in the field of preventive…
Read MoreCHF 500 000 for AC Immune
Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) provide more than USD 500,000 in additional non-dilutive capital to the Swiss company AC Immune SA, a clinical-stage biopharmaceutical Swiss company pioneering precision medicine for neurodegenerative diseases, announced prestigious new grants from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)…
Read More€2M Eurostars funding for a project led by Calciscon
CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer for the measurement of the T50 test. T50 is a unique test for the measurement of calcification propensity in a blood sample. The primary use of T50 is to revolutionize the treatment of patients…
Read MoreVirtual reality glasses used as a diagnostic tool for brain disorders
MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a virtual reality headset. Their tool, neos, has been awarded the first prize by the Ypsomed Innovation Fund. machineMD is an exemplary product of the well-connected Bernese startup ecosystem. Prof Dr Mathias Abegg has been…
Read MoreResistell AG closes its series B first tranche of CHF 8.5 Million
Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered Resistell AG, a leader in phenotypic nanomotion technology for measuring living cells, has taken another major step to achieving its vision by closing a first tranche of its series B financing round,…
Read MoreMICROCITY Neuchâtel, Land of Diagnostic
A Human lean Diagnostic programme in the canton of precision watchmaking The historical heritage of high precision and core competencies in micro and nanotechnologies (micromechanics, microelectronics, advanced manufacturing) as well as its unique expertise in miniaturization, ultra-low energy consumption, reliability and complexity mean that the canton of Neuchâtel can connect all the competencies necessary…
Read MoreSUN Bioscience receives an EPFL Alumni Awards
The two co-founders of SUN bioscience received an EPFL Alumni Award, a price that distinguishes researchers over the course of their careers. Nathalie Brandenberg and Sylke Hoehnel co-founded SUN bioscience in 2016. SUN bioscience offers a 3D microwell platform based on patient-specific organoids. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are…
Read More